The USA Food and Drug Administration (FDA) proposed on Thursday to remove orally administered phenylephrine widely used in over-the-counter nasal decongestants from the active ingredients in syrups for colds and coughs, calling it ineffective. Phenylephrine is widely used in various over-the-counter flu and cold medicines, including popular products like Benadryl, Advil, and Tylenol. Last year, an external panel of experts unanimously voted against the effectiveness of orally administered phenylephrine as a nasal decongestant and added that no further tests are needed to prove the opposite viewpoint. Procter & Gamble and GlaxoSmithKline are among the companies accused of deceiving consumers by including this ingredient in their cold medicines. The FDA is currently seeking public comments on this proposed order. Currently, the above-mentioned companies can continue to sell products containing orally administered phenylephrine as a nasal decongestant.